Compare Merck & Co., Inc. (MRK) vs ON Semiconductor (ON) Price & Performance

Merck & Co., Inc.Trade

ON SemiconductorTrade

Price performance (Past 24H)

Key statistics

Merck & Co., Inc. vs ON Semiconductor — how do they compare? Merck & Co., Inc. trades at $142.89 (market cap $351.28B), while ON Semiconductor trades at $80.69 (market cap $30.92B). The key difference: Merck & Co., Inc. is far larger — about 11.4× ON Semiconductor's market cap, and Merck & Co., Inc. pays a 2.39% dividend while ON Semiconductor pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and ON Semiconductor for 5 Days on average.

	MRK	ON
Market Cap	$351.28B	$30.92B
Volume	7,969,665	11,639,037
Sector	Health	Technology
52-Week High	$156.43	$133.93
52-Week Low	$82.49	$44.90
Typical Hold Time	98 Days	5 Days
Enterprise Value	$398.04B	$31.53B
Dividend Yield	2.39%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Merck & Co., Inc.

Merck (MRK) trades at $142.79, up 0.61% on the day, with a bearish technical signal despite beating earnings estimates in recent quarters. The company reported 2025 revenue of $65.01B and net income of $18.25B, with a high P/E ratio of 113.9 reflecting premium valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while institutional investors have been increasing stakes.

The outlook is mixed: strong analyst consensus (68% buy ratings) and a $158.78 price target suggest upside, but high valuation and bearish technicals pose near-term risks. Key opportunities include pipeline expansion via M&A; risks involve integration challenges and patent pressures.

ON Semiconductor

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRK

18% Buy82% Sell

Avg holding period · 98 Days

75% Buy25% Sell

Avg holding period · 5 Days

Top news

Latest headlines on both assets

MRK

Cantor Fitzgerald raises price targets on Eli Lilly, AbbVie, Merck, and Pfizer amid mixed growth outlooks.24/7 Wall Street · 5 hours agoBullish Global DPP-4 inhibitors market to grow to $15.5B by 2032, driven by type 2 diabetes demand and generics expansion.PRNewsWire · 23 hours agoNeutral HP, Merck, and Seagate paid dividends on Oct 7, with Merck leading in per-share payout and HP offering the highest yield.24/7 Wall Street · 1 day agoBullish View details →

Wolfspeed jumps 14% on $1.5B conditional U.S. Department of War loan commitment24/7 Wall Street · 1 day agoBullish CVS seen as undervalued, ON Semi catching up, Grail too pricey amid FDA uncertainty24/7 Wall Street · 2 days agoBullish View details →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

About ON Semiconductor

Onsemi develops power and sensing semiconductors for automotive, industrial, and energy applications. Its products support functions such as electric vehicle systems, energy conversion, automation, and intelligent sensing.